サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1702369

バルーン弁形成術装置の世界市場：2025年～2033年

Global Balloon Valvuloplasty Devices Market - 2025-2033

出版日
ページ情報
英文 165 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
バルーン弁形成術装置の世界市場：2025年～2033年
出版日: 2025年04月10日
発行: DataM Intelligence
ページ情報: 英文 165 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界のバルーン弁形成術装置の市場規模は、2024年に20億3,000万米ドルに達し、2033年には39億5,000万米ドルに達すると予測され、予測期間の2025年～2033年のCAGRは6.8%となる見込みです。

バルーン弁形成術機器は、心臓弁の狭窄を治療するために使用される医療機器です。弁口を広げ、血流を改善し、症状を軽減します。症状の緩和、回復時間の短縮、入院期間の短縮を目的として、インターベンショナル心臓病学で一般的に使用されています。

世界のバルーン弁形成術装置市場は、大動脈弁狭窄症、僧帽弁狭窄症、肺動脈弁障害などの心臓弁膜症の有病率の上昇によって牽引されています。人口の高齢化と、高血圧、糖尿病、肥満、喫煙などのライフスタイルに関連した危険因子は、これらの状態をさらに悪化させています。バルーン弁形成術は、外科的弁置換術に代わる低侵襲の治療法であり、入院期間の短縮、回復時間の短縮、術後合併症の減少といった利点を提供します。

例えば、世界の心血管系疾患である心臓弁膜症は世界的に増加しており、その中でも4,100万人が罹患しているリウマチ性心疾患は発展途上国で増加しています。これは若年成人人口の増加と、抗生物質、微生物学的検査、心エコー検査へのアクセスが改善され、早期死亡率が低下したためです。

世界のバルーン弁形成術市場は、再狭窄やその他の手技合併症による課題に直面しています。再狭窄とは、手技後に治療した弁が再び狭くなることで、しばしば再手術が必要となり、患者やヘルスケアシステムに負担をかけることになります。これは特に高齢の患者や石灰化がひどい患者で顕著であり、手技の効果が一時的なものになる可能性があります。

その他のリスクとしては、血管合併症、塞栓、不整脈、弁逆流などがあり、患者の予後を悪くします。合併症の可能性があるため、ヘルスケアプロバイダーは、特に外科的弁置換術のようなより耐久性のある代替治療が利用可能な場合には、この手技を広く採用することを躊躇しています。経カテーテル的大動脈弁置換術（TAVR）などの代替治療オプションが利用可能なことも、バルーン弁形成術市場の成長を制限する可能性があります。

当レポートでは、世界のバルーン弁形成術装置市場について調査し、市場の概要とともに、製品タイプ別、用途別、年齢層別、エンドユーザー別、地域別動向、競合情勢、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 市場のイントロダクションと範囲

第2章 経営者の洞察と重要なポイント

第3章 市場力学

  • 影響要因
    • 促進要因
    • 抑制要因
    • 機会
    • 影響分析

第4章 戦略的洞察と業界見通し

  • 市場のリーダーとパイオニア
  • CXOの視点
  • 最新の開発とブレークスルー
  • ケーススタディ/進行中の調査
  • 規制と償還の情勢
  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 特許分析
  • SWOT分析
  • アンメットニーズとギャップ
  • 市場参入と拡大のための推奨戦略
  • シナリオ分析ベストケース、ベースケース、ワーストケースの予測
  • 価格分析と価格動向
  • キーオピニオンリーダー

第5章 製品タイプ別

  • 標準バルーン
  • カッティングバルーン
  • スコアリングバルーン
  • 高圧バルーン
  • 低圧バルーン

第6章 用途別

  • 大動脈弁狭窄症
  • 肺動脈弁狭窄症

第7章 年齢層別

  • 小児
  • 成人

第8章 エンドユーザー別

  • 病院
  • 外来手術センター
  • 専門クリニック
  • その他

第9章 地域市場分析と成長機会

  • 北米
    • 地域特有の主要な動向
      • 米国
      • カナダ
      • メキシコ
  • 欧州
    • 地域特有の主要な動向
      • ドイツ
      • 英国
      • フランス
      • スペイン
      • イタリア
      • その他
  • ラテンアメリカ
    • 地域特有の主要な動向
      • ブラジル
      • アルゼンチン
      • その他
  • アジア太平洋
    • 地域特有の主要な動向
      • 中国
      • インド
      • 日本
      • 韓国
      • その他
  • 中東・アフリカ
    • 地域特有の主要な動向

第10章 競合情勢と市場ポジショニング

  • 競合状況の概要と主要市場参入企業
  • 市場シェア分析とポジショニングマトリックス
  • 戦略的パートナーシップ、合併・買収
  • 製品ポートフォリオとイノベーションにおける主な発展
  • 企業ベンチマーク

第11章 企業プロファイル

  • Medtronic
    • 会社概要
    • 製品ポートフォリオ
    • 財務概要
    • 主な発展
    • SWOT分析
  • Balton
  • Boston Scientific Corporation
  • B. Braun Melsungen AG
  • Cardinal Health, Inc
  • Cook Medical Inc
  • Terumo Corporation
  • Becton, Dickinson and Company（BD）
  • TORAY MEDICAL CO,. LTD.
  • BVM Medical

第12章 仮定と調査手法

第13章 付録

目次
Product Code: MD9460

The global balloon valvuloplasty devices market reached US$ 2.03 billion in 2024 and is expected to reach US$ 3.95 billion by 2033, growing at a CAGR of 6.8% during the forecast period 2025-2033.

Balloon valvuloplasty devices are medical devices used to treat valvular stenosis, a narrowing of heart valves. They widen the valve opening, improve blood flow, and reduce symptoms. They're commonly used in interventional cardiology for symptom relief, shorter recovery times, and reduced hospitalization duration.

Market Dynamics: Drivers & Restraints

Rising Prevalence of Valvular Heart Diseases

The global balloon valvuloplasty devices market is driven by the increasing prevalence of valvular heart diseases, such as aortic stenosis, mitral stenosis, and pulmonary valve disorders. The aging population and lifestyle-related risk factors like hypertension, diabetes, obesity, and smoking further exacerbate these conditions. Balloon valvuloplasty is a minimally invasive alternative to surgical valve replacement, offering benefits like shorter hospital stays, faster recovery times, and reduced post-operative complications.

For instance, valvular heart disease, a global cardiovascular disease, is increasing globally, with rheumatic heart disease, the most common, affecting 41 million people, increasing in developing nations. This is due to the growth of the young adult population and improved access to antibiotics, microbiological testing, and echocardiography, which have reduced premature mortality rates.

Risk of Restenosis and Procedural Complications

The global balloon valvuloplasty devices market faces challenges due to restenosis and other procedural complications. Restenosis, the re-narrowing of the treated valve after the procedure, often requires repeat interventions, burdening patients and healthcare systems. This is particularly evident in elderly patients or those with severe calcification, where the procedure's effectiveness may be temporary.

Other risks include vascular complications, embolization, arrhythmias, and valve regurgitation, leading to adverse patient outcomes. The potential for complications makes healthcare providers hesitant to adopt the procedure widely, especially when more durable alternatives like surgical valve replacement are available. The availability of alternative treatment options, such as transcatheter aortic valve replacement (TAVR), may also limit the growth of the balloon valvuloplasty devices market.

Segment Analysis

The global balloon valvuloplasty devices market is segmented based on product type, application, age group, end user, and region.

Product Type:

The standard balloon from product type segment is expected to dominate the balloon valvuloplasty devices market with the highest market share

Standard balloons are medical devices used in balloon valvuloplasty to dilate narrowed heart valves, restoring blood flow in patients with valvular stenosis. These high-strength balloons, available in various sizes and diameters, are delivered via catheter-based systems and inflated to break calcific deposits, improving valve function in high-risk patients not candidates for open-heart surgery.

The balloon valvuloplasty devices market is growing due to the increasing prevalence of valvular heart diseases, preference for minimally invasive procedures, technological advancements, expanding healthcare infrastructure, and government initiatives. Benefits include reduced hospital stays, faster recovery times, and fewer post-operative complications. Technological advancements and improved access to interventional cardiology in developing regions further support market growth.

Geographical Analysis

North America is expected to hold a significant position in the balloon valvuloplasty devices market with the highest market share

The North American balloon valvuloplasty devices market is growing due to the increasing prevalence of valvular heart diseases, especially among the aging population. Technological advancements and favorable reimbursement policies are driving innovation. Increased awareness among healthcare professionals and patients, coupled with rising healthcare expenditure and government support for cardiovascular disease management, is expected to further accelerate market growth in North America.

For instance, in January 2025, Concept Medical has enrolled the first patient in its MAGICAL trial, comparing its sirolimus-coated balloon to traditional angioplasty for patients with below-the-knee PDA. The company secured an Investigational Device Exemption from the FDA for the MagicTouch PTA and is launching two more trials to evaluate its drug-coated alternative.

Competitive Landscape

The major global players in the balloon valvuloplasty devices market include Medtronic, Balton, Boston Scientific Corporation, B. Braun Melsungen AG, Cardinal Health, Inc., Cook Medical Inc., Terumo Corporation, Becton, Dickinson and Company (BD), TORAY MEDICAL CO,.LTD., and BVM Medical, among others.

Key Developments

  • In February 2025, Cagent Vascular launched the Serranator SL-PRO percutaneous transluminal angioplasty (PTA) serration balloon catheter for chronic limb-threatening ischaemia and pedal disease. The catheter uses Cagent's proven serration technology on a redesigned platform, offering improved deliverability and trackability. It also offers 1,000 times increase in point force compared to plain balloons and a controlled lumen gain with minimal dissection.

Why Purchase the Report?

  • Technological Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global balloon valvuloplasty devices market report delivers a detailed analysis with 70 key tables, more than 74 visually impactful figures and 165 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Application & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Product Type
  • 2.4. Snippet by Application
  • 2.5. Snippet by Age Group
  • 2.6. Snippet by End User
  • 2.7. Snippet by Region

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Rising Prevalence of Valvular Heart Diseases
      • 3.1.1.2. Rise in the Technological Advancements
    • 3.1.2. Restraints
      • 3.1.2.1. Risk of Restenosis and Procedural Complications
      • 3.1.2.2. High Cost of Devices
    • 3.1.3. Opportunity
      • 3.1.3.1. Expansion in Emerging Markets
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established leaders with largest selling Brand
    • 4.1.3. Market leaders with established Product
  • 4.2. CXO Perspectives
  • 4.3. Latest Developments and Breakthroughs
  • 4.4. Case Studies/Ongoing Research
  • 4.5. Regulatory and Reimbursement Landscape
    • 4.5.1. North America
    • 4.5.2. Europe
    • 4.5.3. Asia Pacific
    • 4.5.4. Latin America
    • 4.5.5. Middle East & Africa
  • 4.6. Porter's Five Force Analysis
  • 4.7. Supply Chain Analysis
  • 4.8. Patent Analysis
  • 4.9. SWOT Analysis
  • 4.10. Unmet Needs and Gaps
  • 4.11. Recommended Strategies for Market Entry and Expansion
  • 4.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.13. Pricing Analysis and Price Dynamics
  • 4.14. Key Opinion Leaders

5. By Product Type

  • 5.1. Introduction
    • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 5.1.2. Market Attractiveness Index, By Product Type
  • 5.2. Standard Balloon*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 5.3. Cutting Balloon
  • 5.4. Scoring Balloon
  • 5.5. High-Pressure Balloon
  • 5.6. Low-Pressure Balloon

6. By Application

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 6.1.2. Market Attractiveness Index, By Application
  • 6.2. Aortic Valve Stenosis*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Pulmonary Valve Stenosis

7. By Age Group

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
    • 7.1.2. Market Attractiveness Index, By Age Group
  • 7.2. Pediatric*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Adult

8. By End User

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 8.1.2. Market Attractiveness Index, By End User
  • 8.2. Hospitals*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Ambulatory Surgical Centers
  • 8.4. Specialty Clinics
  • 8.5. Others

9. Regional Market Analysis and Growth Opportunities

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
    • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.7.1. U.S.
      • 9.2.7.2. Canada
      • 9.2.7.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
    • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.7.1. Germany
      • 9.3.7.2. U.K.
      • 9.3.7.3. France
      • 9.3.7.4. Spain
      • 9.3.7.5. Italy
      • 9.3.7.6. Rest of Europe
  • 9.4. Latin America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
    • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.7.1. Brazil
      • 9.4.7.2. Argentina
      • 9.4.7.3. Rest of Latin America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
    • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.7.1. China
      • 9.5.7.2. India
      • 9.5.7.3. Japan
      • 9.5.7.4. South Korea
      • 9.5.7.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
    • 9.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

10. Competitive Landscape and Market Positioning

  • 10.1. Competitive Overview and Key Market Players
  • 10.2. Market Share Analysis and Positioning Matrix
  • 10.3. Strategic Partnerships, Mergers & Acquisitions
  • 10.4. Key Developments in Product Portfolios and Innovations
  • 10.5. Company Benchmarking

11. Company Profiles

  • 11.1. Medtronic*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio
      • 11.1.2.1. Product Description
      • 11.1.2.2. Product Key Performance Indicators (KPIs)
      • 11.1.2.3. Historic and Forecasted Product Sales
      • 11.1.2.4. Product Sales Volume
    • 11.1.3. Financial Overview
      • 11.1.3.1. Company Revenue
      • 11.1.3.2. Geographical Revenue Shares
      • 11.1.3.3. Revenue Forecasts
    • 11.1.4. Key Developments
      • 11.1.4.1. Mergers & Acquisitions
      • 11.1.4.2. Key Product Development Activities
      • 11.1.4.3. Regulatory Approvals, etc.
    • 11.1.5. SWOT Analysis
  • 11.2. Balton
  • 11.3. Boston Scientific Corporation
  • 11.4. B. Braun Melsungen AG
  • 11.5. Cardinal Health, Inc
  • 11.6. Cook Medical Inc
  • 11.7. Terumo Corporation
  • 11.8. Becton, Dickinson and Company (BD)
  • 11.9. TORAY MEDICAL CO,. LTD.
  • 11.10. BVM Medical

LIST NOT EXHAUSTIVE

12. Assumption and Research Methodology

  • 12.1. Data Collection Methods
  • 12.2. Data Triangulation
  • 12.3. Forecasting Techniques
  • 12.4. Data Verification and Validation

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us